HIGHLIGHTS
- who: Jing Luo from the Department of, The Second Xiangya Hospital, Central South University, Changsha, China have published the article: One-Month Outcomes of Intravitreal Anti-VEGF vs. Dexamethasone Implant in the Treatment of Diabetic Macular Edema in Vitrectomized Eyes, in the Journal: (JOURNAL)
- what: This study compared the shot-term response to anti-VEGF agent or Ozurdex in vitrectomized DME patients.
- how: This result is partially consistent with a previous study which showed that neither mean visual acuity nor foveal thickness changed after intravitreal anti-VEGF treatment . The results showed that anti . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.